Acemagnil

Composition

Acemagnil 75 

Each film coated tablet contains:

• Acetylsalicylic Acid BP 75 mg
• Magnesium Hydroxide BP 15.2 mg

Colour: Red Oxide of Iron

Acemagnil 150 mg

Each film coated tablet contains:

• Acetylsalicylic Acid BP 150 mg
• Magnesium Hydroxide BP 30.39 mg .

Colour: Red Oxide of Iron

Indications for use

For the secondary prevention of thrombotic cerebrovascular or cardiovascular disease and following by-pass surgery for relief of the symptoms of flatulence, heartburn, dyspepsia
and indigestion.

Mode of application

Acemagnil 75 

For the secondary prevention of thrombotic cerebrovascular or cardiovascular disease and following by-pass surgery for For the management of cardiovascular or cerebrovascular
disease: The advice of a doctor should be sought before commencing therapy for the first time. The usual dosage, for long term use, is 75-150 mg once daily. In somerelief of the symptoms of flatulence, heartburn, dyspepsia and indigestion. circumstances a higher dose may be appropriate, especially in the short term, and up to 300 mg a day may be used on the advice of a doctor.
In general, acetylsalicylic acids should be used with caution in elderly patients who are more prone to adverse events. The usual adult dose is recommended in the absence of severe renal or hepatic insufficiency. Treatment should be reviewed at regular intervals.

Children: Acetylsalicylic Acid & Magnesium Hydroxide Tablet is not indicated for use in children and young people less than 16 years of age. Method of administration: These tablets should be taken orally with a drink of water.

Acemagnil  150 mg

For the management of cardiovascular or cerebrovascular disease: The advice of a doctor should be sought before commencing therapy for the first time. The usual dosage, for long term use, is 75-150 mg once daily. In some circumstances a higher dose may be appropriate, especially in the short term, and up to 300 mg a day may be used on the advice of a doctor. In general, acetylsalicylic acids should be used with caution in elderly patients who are more prone to adverse events. The usual adult dose is recommended in the absence of severe renal or hepatic insufficiency. Treatment should be reviewed at regular intervals.